Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles

Rafal Farjo; Jeff Skaggs; Alexander B. Quiambao; Mark J. Cooper; Muna I. Naash

doi:10.1371/journal.pone.0000038

journal article Open Access Dec 20, 2006

Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles

Rafal Farjo Jeff Skaggs Alexander B. Quiambao Mark J. Cooper Muna I. Naash

PLoS ONE Vol. 1 No. 1 pp. e38 · Public Library of Science (PLoS)

View at Publisher Save 10.1371/journal.pone.0000038

Topics

No keywords indexed for this article. Browse by subject →

References

61

[1]

V Berry "Missense mutations in MIP underlie autosomal dominant ‘polymorphic’ and lamellar cataracts linked to 12q." Nat Genet (2000) 10.1038/75538

[2]

EM Stone "Identification of a gene that causes primary open angle glaucoma." Science (1997) 10.1126/science.275.5300.668

[3]

GJ Farrar "On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention." Embo J (2002) 10.1093/emboj/21.5.857

[4]

PA Ferreira "Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms." Hum Mol Genet (2005) 10.1093/hmg/ddi272

[5]

RS Molday "Photoreceptor membrane proteins, phototransduction, and retinal degenerative diseases. The Friedenwald Lecture." Invest Ophthalmol Vis Sci (1998)

[6]

J Bennett "Commentary: an aye for eye gene therapy." Hum Gene Ther (2006) 10.1089/hum.2006.17.177

[7]

ML Batten "Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis." PLoS Med (2005) 10.1371/journal.pmed.0020333

[8]

KA Drenser "Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa." Invest Ophthalmol Vis Sci (1998)

[9]

AS Lewin "Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa." Nat Med (1998) 10.1038/nm0898-967

[10]

GM Sarra "Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina." Hum Mol Genet (2001) 10.1093/hmg/10.21.2353

[11]

F Rolling "Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives." Gene Ther (2004) 10.1038/sj.gt.3302366

[12]

J Bennett "Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy." Nat Med (1996) 10.1038/nm0696-649

[13]

Y Chen "RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice." Invest Ophthalmol Vis Sci (2006) 10.1167/iovs.05-0965

[14]

RR Ali "Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy." Nat Genet (2000) 10.1038/77068

[15]

A Dinculescu "Adeno-associated virus-vectored gene therapy for retinal disease." Hum Gene Ther (2005) 10.1089/hum.2005.16.649

[16]

GD Aguirre "Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect." Mol Vis (1998)

[17]

F Marlhens "Mutations in RPE65 cause Leber's congenital amaurosis." Nat Genet (1997) 10.1038/ng1097-139

[18]

GM Acland "Gene therapy restores vision in a canine model of childhood blindness." Nat Genet (2001) 10.1038/ng0501-92

[19]

GM Acland "Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness." Mol Ther (2005) 10.1016/j.ymthe.2005.08.008

[20]

K Narfstrom "Assessment of structure and function over a 3-year period after gene transfer in RPE65-/- dogs." Doc Ophthalmol (2005) 10.1007/s10633-005-3159-0

[21]

DH Hong "A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo." Invest Ophthalmol Vis Sci (2005) 10.1167/iovs.04-1065

[22]

CE Thomas "Progress and problems with the use of viral vectors for gene therapy." Nat Rev Genet (2003) 10.1038/nrg1066

[23]

CL Halbert "Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors." Hum Gene Ther (2006) 10.1089/hum.2006.17.440

[24]

MG Ott "Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1." Nat Med (2006) 10.1038/nm1393

[25]

C Baum "Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors." Hum Gene Ther (2006) 10.1089/hum.2006.17.253

[26]

SE Raper "Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer." Mol Genet Metab (2003) 10.1016/j.ymgme.2003.08.016

[27]

G Liu "Nanoparticles of compacted DNA transfect postmitotic cells." J Biol Chem (2003) 10.1074/jbc.m305776200

[28]

AG Ziady "Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung." Mol Ther (2003) 10.1016/j.ymthe.2003.09.002

[29]

AG Ziady "Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo." Mol Ther (2003) 10.1016/j.ymthe.2003.07.007

[30]

TL Fink "Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles." Gene Ther Epub (2006)

[31]

TH Kowalczyk "Type of polylysine counterion influences morphology and biological function of condensed DNA." Mol Ther (2001)

[32]

MW Konstan "Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution." Hum Gene Ther (2004) 10.1089/hum.2004.15.1255

[33]

G Liu "Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding of the polycation." J Biol Chem (2001) 10.1074/jbc.m105250200

[34]

R Farjo "Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors." J Cell Biol (2006) 10.1083/jcb.200509036

[35]

M Nour "Absence of functional and structural abnormalities associated with expression of EGFP in the retina." Invest Ophthalmol Vis Sci (2004) 10.1167/iovs.03-0663

[36]

AC Martin "Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene." Invest Ophthalmol Vis Sci (2004) 10.1167/iovs.04-0349

[37]

JG Flannery "Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus." Proc Natl Acad Sci U S A (1997) 10.1073/pnas.94.13.6916

[38]

J Bennett "Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina." Proc Natl Acad Sci U S A (1999) 10.1073/pnas.96.17.9920

[39]

M Nour "P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice." Invest Ophthalmol Vis Sci (2003) 10.1167/iovs.03-0453

[40]

S Bauer "Optimization of gene transfer into neonatal rat cardiomyocytes and unmasking of cytomegalovirus promoter silencing." DNA Cell Biol (2005) 10.1089/dna.2005.24.381

[41]

AR Brooks "Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle." J Gene Med (2004) 10.1002/jgm.516

[42]

ZY Chen "Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo." Gene Ther (2004) 10.1038/sj.gt.3302231

[43]

MI Naash "Non-Viral Ocular Gene Transfer for Hereditary Retinal Degeneration." Mol Ther (2006)

[44]

D Kube "Intracellular trafficking of non-targeted stabilized molecular conjugates in human airway epithelia cells." Mol Ther (2003) 10.1016/s1525-0016(16)41407-3

[45]

X Chen "Compacted DNA nanoparticles transfect cells by binding to cell surface nucleolin." Mol Ther (2006) 10.1016/j.ymthe.2006.08.459

[46]

RR Mohan "Gene therapy in the cornea." Prog Retin Eye Res (2005) 10.1016/j.preteyeres.2005.04.001

[47]

AS Jun "Prospects for gene therapy in corneal disease." Eye (2003) 10.1038/sj.eye.6700565

[48]

KR Martin "Gene therapy for optic nerve disease." Eye (2004) 10.1038/sj.eye.6701579

[49]

IA Atencio "p21WAF-1/Cip-1 gene therapy as an adjunct to glaucoma filtration surgery." Curr Opin Mol Ther (2004)

[50]

KR Martin "Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model." Invest Ophthalmol Vis Sci (2003) 10.1167/iovs.02-1332

Showing 50 of 61 references

Cited By

165

Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters

Bart Nieuwenhuis, Elise Laperrousaz · 2023

Gene Therapy

Metrics

165

Citations

61

References

Details

Published: Dec 20, 2006
Vol/Issue: 1(1)
Pages: e38
License: View

Authors

Alexander B. Quiambao

M

Mark J. Cooper

Copernicus Therapeutics Incorporated Cleveland Ohio USA

M

Muna I. Naash

Department of Biomedical Engineering, University of Houston, Houston, TX 77204, USA; College of Optometry, University of Houston, Houston, TX 77204, USA; Department of Biology and Biochemistry, University of Houston, TX 77204, USA

Cite This Article

Rafal Farjo, Jeff Skaggs, Alexander B. Quiambao, et al. (2006). Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles. PLoS ONE, 1(1), e38. https://doi.org/10.1371/journal.pone.0000038

Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles

You May Also Like